Global and China Epilepsy Market Size, Status and Forecast 2020-2026

August 2020 | 125 pages | ID: GC668586B055EN
QYResearch

Abstracts

Global Epilepsy Scope and Market Size
Epilepsy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Epilepsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into

• Partial/focal Seizure
• Generalized Seizure
• Myoclonus Misses
• Negative Myoclonus
• Eyelid Myoclonus
• Laughter
• Others

Market segment by Application, split into

• Hospitals
• Neurology Centers
• Home Care Settings
• Ambulatory Surgical Centers
• Others

Based on regional and country-level analysis, the Epilepsy market has been segmented as follows:

• North America
• United States
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific
• Latin America
• Mexico
• Brazil
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Epilepsy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study

• LivaNova
• Johnson & Johnson Services
• Eisai
• GlaxoSmithKline PLC
• Pfizer
• UCB SA
• Medtronic PLC (Ireland)
• NeuroPace
• Novartis AG
• GW Pharmaceuticals
• Abbott Laboratories
• Sanofi
• Sunovion Pharmaceuticals
• Bausch Health
• Takeda

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Epilepsy Market Size Growth Rate by Type: 2020 VS 2026
  1.2.2 Partial/focal Seizure
  1.2.3 Generalized Seizure
  1.2.4 Myoclonus Misses
  1.2.5 Negative Myoclonus
  1.2.6 Eyelid Myoclonus
  1.2.7 Laughter
  1.2.8 Others
1.3 Market by Application
  1.3.1 Global Epilepsy Market Share by Application: 2020 VS 2026
  1.3.2 Hospitals
  1.3.3 Neurology Centers
  1.3.4 Home Care Settings
  1.3.5 Ambulatory Surgical Centers
  1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Epilepsy Market Perspective (2015-2026)
2.2 Global Epilepsy Growth Trends by Regions
  2.2.1 Epilepsy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Epilepsy Historic Market Share by Regions (2015-2020)
  2.2.3 Epilepsy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Epilepsy Players by Market Size
  3.1.1 Global Top Epilepsy Players by Revenue (2015-2020)
  3.1.2 Global Epilepsy Revenue Market Share by Players (2015-2020)
3.2 Global Epilepsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epilepsy Revenue
3.4 Global Epilepsy Market Concentration Ratio
  3.4.1 Global Epilepsy Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Revenue in 2019
3.5 Key Players Epilepsy Area Served
3.6 Key Players Epilepsy Product Solution and Service
3.7 Date of Enter into Epilepsy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 EPILEPSY BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Epilepsy Historic Market Size by Type (2015-2020)
4.2 Global Epilepsy Forecasted Market Size by Type (2021-2026)

5 EPILEPSY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Epilepsy Historic Market Size by Application (2015-2020)
5.2 Global Epilepsy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Epilepsy Market Size (2015-2026)
6.2 North America Epilepsy Market Size by Type (2015-2020)
6.3 North America Epilepsy Market Size by Application (2015-2020)
6.4 North America Epilepsy Market Size by Country (2015-2020)
  6.4.1 United States
  6.4.2 Canada

7 EUROPE

7.1 Europe Epilepsy Market Size (2015-2026)
7.2 Europe Epilepsy Market Size by Type (2015-2020)
7.3 Europe Epilepsy Market Size by Application (2015-2020)
7.4 Europe Epilepsy Market Size by Country (2015-2020)
  7.4.1 Germany
  7.4.2 France
  7.4.3 U.K.
  7.4.4 Italy
  7.4.5 Russia
  7.4.6 Nordic
  7.4.7 Rest of Europe

8 CHINA

8.1 China Epilepsy Market Size (2015-2026)
8.2 China Epilepsy Market Size by Type (2015-2020)
8.3 China Epilepsy Market Size by Application (2015-2020)
8.4 China Epilepsy Market Size by Region (2015-2020)
  8.4.1 China
  8.4.2 Japan
  8.4.3 South Korea
  8.4.4 Southeast Asia
  8.4.5 India
  8.4.6 Australia
  8.4.7 Rest of Asia-Pacific

9 JAPAN

9.1 Japan Epilepsy Market Size (2015-2026)
9.2 Japan Epilepsy Market Size by Type (2015-2020)
9.3 Japan Epilepsy Market Size by Application (2015-2020)
9.4 Japan Epilepsy Market Size by Country (2015-2020)
  9.4.1 Mexico
  9.4.2 Brazil

10 SOUTHEAST ASIA

10.1 Southeast Asia Epilepsy Market Size (2015-2026)
10.2 Southeast Asia Epilepsy Market Size by Type (2015-2020)
10.3 Southeast Asia Epilepsy Market Size by Application (2015-2020)
10.4 Southeast Asia Epilepsy Market Size by Country (2015-2020)
  10.4.1 Turkey
  10.4.2 Saudi Arabia
  10.4.3 UAE
  10.4.4 Rest of Middle East & Africa

11KEY PLAYERS PROFILES

11.1 LivaNova
  11.1.1 LivaNova Company Details
  11.1.2 LivaNova Business Overview
  11.1.3 LivaNova Epilepsy Introduction
  11.1.4 LivaNova Revenue in Epilepsy Business (2015-2020))
  11.1.5 LivaNova Recent Development
11.2 Johnson & Johnson Services
  11.2.1 Johnson & Johnson Services Company Details
  11.2.2 Johnson & Johnson Services Business Overview
  11.2.3 Johnson & Johnson Services Epilepsy Introduction
  11.2.4 Johnson & Johnson Services Revenue in Epilepsy Business (2015-2020)
  11.2.5 Johnson & Johnson Services Recent Development
11.3 Eisai
  11.3.1 Eisai Company Details
  11.3.2 Eisai Business Overview
  11.3.3 Eisai Epilepsy Introduction
  11.3.4 Eisai Revenue in Epilepsy Business (2015-2020)
  11.3.5 Eisai Recent Development
11.4 GlaxoSmithKline PLC
  11.4.1 GlaxoSmithKline PLC Company Details
  11.4.2 GlaxoSmithKline PLC Business Overview
  11.4.3 GlaxoSmithKline PLC Epilepsy Introduction
  11.4.4 GlaxoSmithKline PLC Revenue in Epilepsy Business (2015-2020)
  11.4.5 GlaxoSmithKline PLC Recent Development
11.5 Pfizer
  11.5.1 Pfizer Company Details
  11.5.2 Pfizer Business Overview
  11.5.3 Pfizer Epilepsy Introduction
  11.5.4 Pfizer Revenue in Epilepsy Business (2015-2020)
  11.5.5 Pfizer Recent Development
11.6 UCB SA
  11.6.1 UCB SA Company Details
  11.6.2 UCB SA Business Overview
  11.6.3 UCB SA Epilepsy Introduction
  11.6.4 UCB SA Revenue in Epilepsy Business (2015-2020)
  11.6.5 UCB SA Recent Development
11.7 Medtronic PLC (Ireland)
  11.7.1 Medtronic PLC (Ireland) Company Details
  11.7.2 Medtronic PLC (Ireland) Business Overview
  11.7.3 Medtronic PLC (Ireland) Epilepsy Introduction
  11.7.4 Medtronic PLC (Ireland) Revenue in Epilepsy Business (2015-2020)
  11.7.5 Medtronic PLC (Ireland) Recent Development
11.8 NeuroPace
  11.8.1 NeuroPace Company Details
  11.8.2 NeuroPace Business Overview
  11.8.3 NeuroPace Epilepsy Introduction
  11.8.4 NeuroPace Revenue in Epilepsy Business (2015-2020)
  11.8.5 NeuroPace Recent Development
11.9 Novartis AG
  11.9.1 Novartis AG Company Details
  11.9.2 Novartis AG Business Overview
  11.9.3 Novartis AG Epilepsy Introduction
  11.9.4 Novartis AG Revenue in Epilepsy Business (2015-2020)
  11.9.5 Novartis AG Recent Development
11.10 GW Pharmaceuticals
  11.10.1 GW Pharmaceuticals Company Details
  11.10.2 GW Pharmaceuticals Business Overview
  11.10.3 GW Pharmaceuticals Epilepsy Introduction
  11.10.4 GW Pharmaceuticals Revenue in Epilepsy Business (2015-2020)
  11.10.5 GW Pharmaceuticals Recent Development
11.11 Abbott Laboratories
  10.11.1 Abbott Laboratories Company Details
  10.11.2 Abbott Laboratories Business Overview
  10.11.3 Abbott Laboratories Epilepsy Introduction
  10.11.4 Abbott Laboratories Revenue in Epilepsy Business (2015-2020)
  10.11.5 Abbott Laboratories Recent Development
11.12 Sanofi
  10.12.1 Sanofi Company Details
  10.12.2 Sanofi Business Overview
  10.12.3 Sanofi Epilepsy Introduction
  10.12.4 Sanofi Revenue in Epilepsy Business (2015-2020)
  10.12.5 Sanofi Recent Development
11.13 Sunovion Pharmaceuticals
  10.13.1 Sunovion Pharmaceuticals Company Details
  10.13.2 Sunovion Pharmaceuticals Business Overview
  10.13.3 Sunovion Pharmaceuticals Epilepsy Introduction
  10.13.4 Sunovion Pharmaceuticals Revenue in Epilepsy Business (2015-2020)
  10.13.5 Sunovion Pharmaceuticals Recent Development
11.14 Bausch Health
  10.14.1 Bausch Health Company Details
  10.14.2 Bausch Health Business Overview
  10.14.3 Bausch Health Epilepsy Introduction
  10.14.4 Bausch Health Revenue in Epilepsy Business (2015-2020)
  10.14.5 Bausch Health Recent Development
11.15 Takeda
  10.15.1 Takeda Company Details
  10.15.2 Takeda Business Overview
  10.15.3 Takeda Epilepsy Introduction
  10.15.4 Takeda Revenue in Epilepsy Business (2015-2020)
  10.15.5 Takeda Recent Development

12ANALYST'S VIEWPOINTS/CONCLUSIONS

13APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Epilepsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Partial/focal Seizure
Table 4. Key Players of Generalized Seizure
Table 5. Key Players of Myoclonus Misses
Table 6. Key Players of Negative Myoclonus
Table 7. Key Players of Eyelid Myoclonus
Table 8. Key Players of Laughter
Table 9. Key Players of Others
Table 10. Global Epilepsy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Epilepsy Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Epilepsy Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Epilepsy Market Share by Regions (2015-2020)
Table 14. Global Epilepsy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Epilepsy Market Share by Regions (2021-2026)
Table 16. Epilepsy Market Market Trends
Table 17. Epilepsy Market Drivers
Table 18. Epilepsy Market Challenges
Table 19. Epilepsy Market Restraints
Table 20. Global Epilepsy Revenue by Players (2015-2020) (US$ Million)
Table 21. Global Epilepsy Market Share by Players (2015-2020)
Table 22. Global Top Epilepsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy as of 2019)
Table 23. Global Epilepsy by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Epilepsy Product Solution and Service
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Epilepsy Market Size by Type (2015-2020) (US$ Million)
Table 28. Global Epilepsy Market Size Share by Type (2015-2020)
Table 29. Global Epilepsy Revenue Market Share by Type (2021-2026)
Table 30. Global Epilepsy Market Size Share by Application (2015-2020)
Table 31. Global Epilepsy Market Size by Application (2015-2020) (US$ Million)
Table 32. Global Epilepsy Market Size Share by Application (2021-2026)
Table 33. North America Epilepsy Market Size by Type (2015-2020) (US$ Million)
Table 34. North America Epilepsy Market Share by Type (2015-2020)
Table 35. North America Epilepsy Market Size by Application (2015-2020) (US$ Million)
Table 36. North America Epilepsy Market Share by Application (2015-2020)
Table 37. North America Epilepsy Market Size by Country (US$ Million) (2015-2020)
Table 38. North America Epilepsy Market Share by Country (2015-2020)
Table 39. Europe Epilepsy Market Size by Type (2015-2020) (US$ Million)
Table 40. Europe Epilepsy Market Share by Type (2015-2020)
Table 41. Europe Epilepsy Market Size by Application (2015-2020) (US$ Million)
Table 42. Europe Epilepsy Market Share by Application (2015-2020)
Table 43. Europe Epilepsy Market Size by Country (US$ Million) (2015-2020)
Table 44. Europe Epilepsy Market Share by Country (2015-2020)
Table 45. China Epilepsy Market Size by Type (2015-2020) (US$ Million)
Table 46. China Epilepsy Market Share by Type (2015-2020)
Table 47. China Epilepsy Market Size by Application (2015-2020) (US$ Million)
Table 48. China Epilepsy Market Share by Application (2015-2020)
Table 49. China Epilepsy Market Size by Region (US$ Million) (2015-2020)
Table 50. China Epilepsy Market Share by Region (2015-2020)
Table 51. Japan Epilepsy Market Size by Type (2015-2020) (US$ Million)
Table 52. Japan Epilepsy Market Share by Type (2015-2020)
Table 53. Japan Epilepsy Market Size by Application (2015-2020) (US$ Million)
Table 54. Japan Epilepsy Market Share by Application (2015-2020)
Table 55. Japan Epilepsy Market Size by Country (US$ Million) (2015-2020)
Table 56. Japan Epilepsy Market Share by Country (2015-2020)
Table 57. Southeast Asia Epilepsy Market Size by Type (2015-2020) (US$ Million)
Table 58. Southeast Asia Epilepsy Market Share by Type (2015-2020)
Table 59. Southeast Asia Epilepsy Market Size by Application (2015-2020) (US$ Million)
Table 60. Southeast Asia Epilepsy Market Share by Application (2015-2020)
Table 61. Southeast Asia Epilepsy Market Size by Country (US$ Million) (2015-2020)
Table 62. Southeast Asia Epilepsy Market Share by Country (2015-2020)
Table 63. LivaNova Company Details
Table 64. LivaNova Business Overview
Table 65. LivaNova Product
Table 66. LivaNova Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 67. LivaNova Recent Development
Table 68. Johnson & Johnson Services Company Details
Table 69. Johnson & Johnson Services Business Overview
Table 70. Johnson & Johnson Services Product
Table 71. Johnson & Johnson Services Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 72. Johnson & Johnson Services Recent Development
Table 73. Eisai Company Details
Table 74. Eisai Business Overview
Table 75. Eisai Product
Table 76. Eisai Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 77. Eisai Recent Development
Table 78. GlaxoSmithKline PLC Company Details
Table 79. GlaxoSmithKline PLC Business Overview
Table 80. GlaxoSmithKline PLC Product
Table 81. GlaxoSmithKline PLC Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 82. GlaxoSmithKline PLC Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Product
Table 86. Pfizer Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 87. Pfizer Recent Development
Table 88. UCB SA Company Details
Table 89. UCB SA Business Overview
Table 90. UCB SA Product
Table 91. UCB SA Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 92. UCB SA Recent Development
Table 93. Medtronic PLC (Ireland) Company Details
Table 94. Medtronic PLC (Ireland) Business Overview
Table 95. Medtronic PLC (Ireland) Product
Table 96. Medtronic PLC (Ireland) Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 97. Medtronic PLC (Ireland) Recent Development
Table 98. NeuroPace Business Overview
Table 99. NeuroPace Product
Table 100. NeuroPace Company Details
Table 101. NeuroPace Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 102. NeuroPace Recent Development
Table 103. Novartis AG Company Details
Table 104. Novartis AG Business Overview
Table 105. Novartis AG Product
Table 106. Novartis AG Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 107. Novartis AG Recent Development
Table 108. GW Pharmaceuticals Company Details
Table 109. GW Pharmaceuticals Business Overview
Table 110. GW Pharmaceuticals Product
Table 111. GW Pharmaceuticals Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 112. GW Pharmaceuticals Recent Development
Table 113. Abbott Laboratories Company Details
Table 114. Abbott Laboratories Business Overview
Table 115. Abbott Laboratories Product
Table 116. Abbott Laboratories Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 117. Abbott Laboratories Recent Development
Table 118. Sanofi Company Details
Table 119. Sanofi Business Overview
Table 120. Sanofi Product
Table 121. Sanofi Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 122. Sanofi Recent Development
Table 123. Sunovion Pharmaceuticals Company Details
Table 124. Sunovion Pharmaceuticals Business Overview
Table 125. Sunovion Pharmaceuticals Product
Table 126. Sunovion Pharmaceuticals Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 127. Sunovion Pharmaceuticals Recent Development
Table 128. Bausch Health Company Details
Table 129. Bausch Health Business Overview
Table 130. Bausch Health Product
Table 131. Bausch Health Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 132. Bausch Health Recent Development
Table 133. Takeda Company Details
Table 134. Takeda Business Overview
Table 135. Takeda Product
Table 136. Takeda Revenue in Epilepsy Business (2015-2020) (US$ Million)
Table 137. Takeda Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Epilepsy Market Share by Type: 2020 VS 2026
Figure 2. Partial/focal Seizure Features
Figure 3. Generalized Seizure Features
Figure 4. Myoclonus Misses Features
Figure 5. Negative Myoclonus Features
Figure 6. Eyelid Myoclonus Features
Figure 7. Laughter Features
Figure 8. Others Features
Figure 9. Global Epilepsy Market Share by Application: 2020 VS 2026
Figure 10. Hospitals Case Studies
Figure 11. Neurology Centers Case Studies
Figure 12. Home Care Settings Case Studies
Figure 13. Ambulatory Surgical Centers Case Studies
Figure 14. Others Case Studies
Figure 15. Epilepsy Report Years Considered
Figure 16. Global Epilepsy Market Size (US$ Million), YoY Growth 2015-2026
Figure 17. Global Epilepsy Market Share by Regions: 2020 VS 2026
Figure 18. Global Epilepsy Market Share by Regions (2021-2026)
Figure 19. Global Epilepsy Market Share by Players in 2019
Figure 20. Global Top Epilepsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Epilepsy Revenue in 2019
Figure 22. North America Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. United States Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Canada Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Europe Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Germany Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. France Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. U.K. Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Italy Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Russia Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Nordic Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Europe Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Asia-Pacific Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. China Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Japan Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. South Korea Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Southeast Asia Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. India Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Australia Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Rest of Asia-Pacific Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Latin America Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Mexico Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Brazil Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Middle East & Africa Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Turkey Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Saudi Arabia Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. UAE Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. Rest of Middle East & Africa Epilepsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 49. LivaNova Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 50. Johnson & Johnson Services Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 51. Eisai Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 52. GlaxoSmithKline PLC Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 53. Pfizer Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 54. UCB SA Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 55. Medtronic PLC (Ireland) Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 56. NeuroPace Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 57. Novartis AG Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 58. GW Pharmaceuticals Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 59. Abbott Laboratories Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 60. Sanofi Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 61. Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 62. Bausch Health Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 63. Takeda Revenue Growth Rate in Epilepsy Business (2015-2020)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed